58 related articles for article (PubMed ID: 33125112)
21. Prevaccination distribution of human papillomavirus types in Italian women with high-risk lesions and cervical neoplasia.
De Francesco MA; Gargiulo F; Schreiber C; Ciravolo G; Salinaro F; Manca N
Intervirology; 2010; 53(6):417-25. PubMed ID: 20606464
[TBL] [Abstract][Full Text] [Related]
22. Detection of human papillomavirus DNA in patients referred to a family practice colposcopy clinic.
Holman JR
J Am Board Fam Pract; 1996; 9(3):162-6. PubMed ID: 8743228
[TBL] [Abstract][Full Text] [Related]
23. Quantitative analysis of the relationship between microRNA‑124a, -34b and -203 gene methylation and cervical oncogenesis.
Botezatu A; Goia-Rusanu CD; Iancu IV; Huica I; Plesa A; Socolov D; Ungureanu C; Anton G
Mol Med Rep; 2011; 4(1):121-8. PubMed ID: 21461574
[TBL] [Abstract][Full Text] [Related]
24. The natural history of cervical HPV infection: unresolved issues.
Woodman CB; Collins SI; Young LS
Nat Rev Cancer; 2007 Jan; 7(1):11-22. PubMed ID: 17186016
[TBL] [Abstract][Full Text] [Related]
25. Methylated Host Cell Gene Promoters and Human Papillomavirus Type 16 and 18 Predicting Cervical Lesions and Cancer.
Milutin Gašperov N; Sabol I; Planinić P; Grubišić G; Fistonić I; Ćorušić A; Grce M
PLoS One; 2015; 10(6):e0129452. PubMed ID: 26057381
[TBL] [Abstract][Full Text] [Related]
26. Molecular and pathological basis of HPV-negative cervical adenocarcinoma seen in a global study.
Jenkins D; Molijn A; Kazem S; Pirog EC; Alemany L; de Sanjosé S; Dinjens W; Quint W
Int J Cancer; 2020 Nov; 147(9):2526-2536. PubMed ID: 32474915
[TBL] [Abstract][Full Text] [Related]
27. Correlation of hTERT Expression with Cervical Cytological Abnormalities and Human Papillomavirus Infection.
Zejnullahu VA; Zejnullahu VA; Josifovska S; Vukovik N; Pakovski K; Panov S
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2017 Dec; 38(3):143-151. PubMed ID: 29668478
[TBL] [Abstract][Full Text] [Related]
28. [Diagnostic significance of human papillomavirus overestimated].
Giard RW; Coebergh JW
Ned Tijdschr Geneeskd; 2003 Feb; 147(7):277-80. PubMed ID: 12622003
[TBL] [Abstract][Full Text] [Related]
29. Response.
Wentzensen N; Fetterman B; Castle P; Schiffman M; Wood S; Tokugawa D; Bodelon C; Poitras N; Lorey T; Kinney W
J Natl Cancer Inst; 2016 Feb; 108(2):. PubMed ID: 26711869
[No Abstract] [Full Text] [Related]
30. Cervical Carcinoma: Oncobiology and Biomarkers.
Volkova LV; Pashov AI; Omelchuk NN
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830452
[TBL] [Abstract][Full Text] [Related]
31. Qualitative and quantitative changes in mitochondrial DNA associated with cervical cancer: A comprehensive review.
Pereira IOA; Silva NNT; Lima AA; da Silva GN
Environ Mol Mutagen; 2024; 65(3-4):143-152. PubMed ID: 38523463
[TBL] [Abstract][Full Text] [Related]
32. Promoter polymorphisms of ST3GAL4 and ST6GAL1 genes and associations with risk of premalignant and malignant lesions of the cervix.
Rivera-Juarez Mde L; Rosas-Murrieta NH; Mendieta-Carmona V; Hernandez-Pacheco RE; Zamora-Ginez I; Rodea-Avila C; Apresa-Garcia T; Garay-Villar O; Aguilar-Lemarroy A; Jave-Suarez LF; Diaz-Orea MA; Milflores-Flores L; Reyes-Salinas JS; Ceja-Utrera FJ; Vazquez-Zamora VJ; Vargas-Maldonado T; Reyes-Carmona S; Sosa-Jurado F; Santos-Lopez G; Reyes-Leyva J; Vallejo-Ruiz V
Asian Pac J Cancer Prev; 2014; 15(3):1181-6. PubMed ID: 24606438
[TBL] [Abstract][Full Text] [Related]
33. Modeling the dynamics of chromosomal alteration progression in cervical cancer: A computational model.
Cabrera-Becerril A; Vargas-De-León C; Hernández S; Miramontes P; Peralta R
PLoS One; 2017; 12(7):e0180882. PubMed ID: 28723940
[TBL] [Abstract][Full Text] [Related]
34. Diagnosis of Early Cervical Cancer with a Multimodal Magnetic Resonance Image under the Artificial Intelligence Algorithm.
Zhang Z; Zhang C; Xiao L; Zhang S
Contrast Media Mol Imaging; 2022; 2022():6495309. PubMed ID: 35386728
[TBL] [Abstract][Full Text] [Related]
35. Molecular alterations and clinical relevance in cervical carcinoma and precursors (Review).
Sheng J; Xiang Y; Shang L; He Q
Oncol Rep; 2020 Dec; 44(6):2397-2405. PubMed ID: 33125112
[TBL] [Abstract][Full Text] [Related]
36. ASC-US diagnosis and triage.
Del Mistro A
Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S2-4. PubMed ID: 17727939
[No Abstract] [Full Text] [Related]
37. [Microsatellite instability and human papilloma virus genotypes in preneoplastic and neoplastic uterine cervix lesions].
Roa S JC; Martínez S R; Montenegro S; Roa E I; Capurro V I; Ibacache S G; Melo A A
Rev Med Chil; 2007 Jan; 135(1):37-44. PubMed ID: 17369982
[TBL] [Abstract][Full Text] [Related]
38. microRNA-944 overexpression is a biomarker for poor prognosis of advanced cervical cancer.
Park S; Kim J; Eom K; Oh S; Kim S; Kim G; Ahn S; Park KH; Chung D; Lee H
BMC Cancer; 2019 May; 19(1):419. PubMed ID: 31060525
[TBL] [Abstract][Full Text] [Related]
39. DNA methylation and detection of cervical cancer and precancerous lesions using molecular methods.
Mersakova S; Nachajova M; Szepe P; Kasajova PS; Halasova E
Tumour Biol; 2016 Jan; 37(1):23-7. PubMed ID: 26459314
[TBL] [Abstract][Full Text] [Related]
40. Human papillomavirus mRNA and p16 detection as biomarkers for the improved diagnosis of cervical neoplasia.
Cuschieri K; Wentzensen N
Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2536-45. PubMed ID: 18842994
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
